Cargando…

Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy

BACKGROUND: We previously developed cabazitaxel (CTX)-loaded human serum albumin nanoparticles (NPs-CTX) via a self-assembly method, and these NPs showed efficacy in prostate cancer therapy. Many studies have shown that the levels of folic acid (FA) receptor on the surface of various tumor cells are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yating, Zhao, Yarong, Teng, Shanshan, Hao, Fei, Zhang, Huan, Meng, Fanchao, Zhao, Xiuting, Zheng, Xiaolong, Bi, Ye, Yao, Yicheng, Lee, Robert J, Teng, Lesheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306057/ https://www.ncbi.nlm.nih.gov/pubmed/30613142 http://dx.doi.org/10.2147/IJN.S181296

Ejemplares similares

Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel
por: Meng, Fanchao, et al.
Publicado: (2019)

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer
por: Qu, Na, et al.
Publicado: (2016)

Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation
por: Sun, Yating, et al.
Publicado: (2017)

Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
por: Qu, Na, et al.
Publicado: (2019)

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer
por: Wan, Zhong, et al.
Publicado: (2020)

Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis
por: Zhao, Yarong, et al.
Publicado: (2022)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
por: Wang, Xi, et al.
Publicado: (2019)

Correction: Wang et al. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma. Molecules 2019, 24, 3540
por: Wang, Xi, et al.
Publicado: (2022)

A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine
por: Bi, Ye, et al.
Publicado: (2020)

Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release
por: Yang, Zhihang, et al.
Publicado: (2020)

Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting
por: Hiremath, Chinmay G., et al.
Publicado: (2018)

Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo
por: Dong, Yanan, et al.
Publicado: (2019)

Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application
por: Katona, Gábor, et al.
Publicado: (2021)

Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017)

Thiophene Derivatives as Anticancer Agents and Their Delivery to Tumor Cells Using Albumin Nanoparticles
por: Cai, Guangsheng, et al.
Publicado: (2019)

Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
por: Yang, Rui, et al.
Publicado: (2014)

Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson’s Disease via Oral Gavage
por: Xu, Kai, et al.
Publicado: (2023)

Self-Interaction of Human Serum Albumin: A Formulation Perspective
por: Sønderby, Pernille, et al.
Publicado: (2018)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Serum Albumin Nanoparticles: Problems and Prospects
por: Hornok, Viktória
Publicado: (2021)

Enhanced Bioavailability of Dihydrotanshinone I–Bovine Serum Albumin Nanoparticles for Stroke Therapy
por: Ren, Yanru, et al.
Publicado: (2021)

Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma
por: Jeng, Long-Bin, et al.
Publicado: (2023)

Exosomes in cancer immunoediting and immunotherapy
por: Zhao, Yarong, et al.
Publicado: (2022)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function
por: Lampe, Jana B., et al.
Publicado: (2023)

Simultaneous Binding of Folic Acid and Methotrexate to Human Serum Albumin: Insights into the Structural Changes of Protein and the Location and Competitive Displacement of Drugs
por: Panja, Sudipta, et al.
Publicado: (2018)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

Cabazitaxel Induced Thrombotic Microangiopathy in a Patient with Prostate Cancer
por: Nlandu, Yannick, et al.
Publicado: (2019)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Development of a Plasmonic Sensor for a Chemotherapeutic Agent Cabazitaxel
por: Aşır, Süleyman, et al.
Publicado: (2022)

Association between serum albumin levels and paroxysmal atrial fibrillation by gender in a Chinese population: a case–control study
por: Zhong, Xia, et al.
Publicado: (2022)

Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
por: Liu, Jiaxin, et al.
Publicado: (2019)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi, Ye, et al.
Publicado: (2018)

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
por: Xie, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0c6m33rh0fov61rcrc28ll1tdt